The ADC targets CD79b on B cells, is internalized, and releases MMAE; MMAE binds beta-tubulin (vinca site) to disrupt microtubules, causing G2/M arrest and apoptosis in CD79b-positive cells. Tubulin expression alone does not trigger killing.